Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Amway Herbal Drink
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Skin Laxity
1 trial -
Anlotinib Hydrochloride
The First People's Hospital of Lianyungang
Non-Small-Cell Lung
1 trial -
Anlotinib hydrochloride
The First People's Hospital of Lianyungang
Non-Small-Cell Lung Cancer
2 trials -
Anti-HER2 CAR-T cells
The First People's Hospital of Lianyungang
HER2-positive Advanced Malignant Solid Tumors
1 trial -
Anti-infective therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis Adult
1 trial -
AntiPlatelet therapy
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
Antibiotic selection based on the antibiotic susceptibility testing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastritis
1 trial -
Antioxidant
AYTU BIOPHARMA, INC
Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)
1 trial -
Antioxidant Berry Supplementation
United Therapeutics Europe Ltd
Heat Intolerance
1 trial -
Anvitra Gastric Suspension
Hong Kong Baptist University
GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency
1 trial -
Apolipoprotein (ApoE) detection
Grace Therapeutics
Senile Plaques
1 trial -
Apple Cider Vinegar
United Therapeutics Europe Ltd
Kidney Stones, Urolithiasis, Hypocitraturia
1 trial -
Arcofolin® 5-Methyltetrahydrofolate
United Therapeutics Europe Ltd
Pre-Eclampsia
1 trial -
Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial -
Artificial intelligence-assisted chest X-ray in TB screening
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis (TB)
1 trial -
Aspirin
The First People's Hospital of Lianyungang
Anterior Ischemic Optic Neuropathy
1 trial -
Aspirin
Regeneron UK Limited
Healthy Volunteer
1 trial -
Astaxanthin (2mg)+Lycopene (1.8mg)+D-Alpha-Tocopherol (10IU)
United Therapeutics Europe Ltd
Skin Aging
1 trial -
Atorvastatin
The First People's Hospital of Lianyungang
Contrast-induced Acute Kidney Injury
1 trial -
Atorvastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atherosclerosis
1 trial -
Atorvastatin 20 Mg Oral Tablet
The First People's Hospital of Lianyungang
Atherosclerotic Cardiovascular Disease
1 trial -
Atorvastatin Calcium 20Mg Tab
The First People's Hospital of Lianyungang
Hyperlipidemias
1 trial -
Atosiban
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
Azithromycin
United Therapeutics Europe Ltd
Malnutrition in Pregnancy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources